Validity and Reliability of the Perineal Assessment Tool
- Wed, 9/3/08 - 10:24am
- 0 Comments
- 9032 reads
I ncontinence has a major impact on health and quality of life. In the general population, fecal incontinence affects approximately 2% of adults and urinary incontinence affects approximately 30% of adults.1,2 Dermatitis is a common problem for individuals experiencing incontinence. This skin condition affects all age groups, races, and genders. Up to 30% of hospitalized adult patients have been reported to have perineal dermatitis.3 Additionally, experts cite incontinence as a major risk factor in the development of pressure ulcers. The presence of pressure ulcers increases hospital stays up to five times longer than when none are present and can cost up to an additional $35,000 for treatment depending on the severity and stages of the wounds.4
Perineal skin injury resulting from incontinence has been found in as many as 33% of hospitalized adults.3 Products such as underpads and adult briefs commonly used with incontinent patients contribute to perineal skin injury by trapping moisture against the skin.5 To address the problem of perineal skin injury, the Perineal Assessment Tool (PAT) was developed through literature review. The PAT is a four-item instrument (see Table 1). The framework for the PAT is based on four factors that are determinants in perineal skin breakdown. These constructs include duration of irritant, intensity/type of irritant, perineal skin condition, and contributing factors that may cause diarrhea. Each subscale reflects degrees of risk factors. All subscales are rated from 1 (least risk) to 3 (most risk). Each rating has a descriptor and a description of each level of the scale. Total scores can range from 4 (least risk) to 12 (most risk).
Literature Review
Duration of irritant refers to the amount of time the skin is exposed to an irritant (ie, urine and/or stool). Skin wetness has been defined as fluid in contact with the skin for 2 or more hours.6 The Braden Scale for predicting pressure ulcers has a subscale for moisture. The Braden subscale definition for moisture is "degree to which skin is exposed to moisture." The Braden Scale further defines degree to which skin is exposed by frequency of garment/linen change: constantly moist (dampness is detected every time patient is moved or turned); often but not always moist (linen changes at least once a shift); occasionally moist (linen change once a day); and rarely moist (skin is usually dry).7
Intensity of irritant refers to the strength and ability of the irritant to cause epidermal barrier disruption in human skin. Factors that correlate with barrier disruption include moisture, increased pH, and invasion of microorganisms. Moist or wet skin has a higher pH than dry skin and is more permeable to irritants and bacteria.6,8 Stool from the large bowel is usually formed and has less moisture. In contrast, small bowel discharge is liquid and reported to be a strong irritant to the skin.9 Studies show that prolonged occlusive exposure to digestive enzymes in feces causes erythema and epidermal barrier disruption in humans. Digestive enzymes with higher pH have been associated with more severe skin alterations.10 The intestine is a natural reservoir of microorganisms that are exposed to the skin through feces.8
1. Urinary Incontinence in Adults Guideline Panel. Clinical Practice Guideline Number 2: Urinary Incontinence in Adults. Rockville, Md.: U.S. Department of Health and Human Services. Public Health Service. Agency for Health Care Policy and Research, 1996 AHCPR Publication.
2. McCormick KA. Research. From clinical trial to health policy - research on urinary incontinence in the adult, Part I. J Prof Nurs. 1991;7(3):147.
3. Lyder CH , Perineal dermatitis in the elderly. A critical review of the literature. J Gerontological Nursing. 1997:23(12):5-10.
4. Panel for the Prediction and Prevention of Pressure Ulcers in Adults. Clinical Practice Guideline Number 3: Pressure Ulcers in Adults: Prediction and Prevention. Rockville, Md.: U.S. Department of Health and Human Services. Public Health Service. Agency for Health Care Policy and Research, 1992. AHCPR Publication 92-0047.
5. Garvin G. Skin care considerations in the neonate for the ET nurse. Journal of Enterostomal Therapy. 1990;17(6):225-230.
6. Faria DT, Shwayder T, Krull EA. Perineal skin injury: extrinsic environmental risk factors. Ostomy/Wound Management. 1992:42(7):28-37.
7. Bergstrom N, Braden B. A conceptual schema for the study of the etiology of pressure sores. Rehabilitation Nursing. 1987;12(1):8-12.
8. Storer-Brown D, Sears M. Perineal dermatitis: a conceptual framework. Ostomy/Wound Management. 1993;39(7):20-26.
9. Fiers S, Thayer D. Management of intractable incontinence. In: Dougherty DB. Urinary and Fecal Incontinence: Nursing Management, 2nd edition. St. Louis, Mo.: Mosby; 2000:183-207.
10. Anderson PH, Bucher AP, Saeed I, Lee JA, Davis LA, Maibach HI. Faecal enzymes: in vivo human skin irritation. Contact Dermatitis. 1994;30:152-158.
11. Scardillo J, Aronovitch SA. Successfully managing incontinence-related irritant dermatitis across the lifespan. Ostomy/Wound Management. 1999;45(4):36-44.
12. Haugen V. Perineal skin care for patients with frequent diarrhea or fecal incontinence. Gastroenterology Nursing. 1997;20(3):87-90.
13. McFarland LV. Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control. 1995;23(5):295-305.
14. Storer-Brown D. Perineal dermatitis: can we measure it? Ostomy/Wound Management. 1993;39(7):8-32.
15. Piloian B. Defining characteristics of the nursing diagnosis "High risk for impaired skin integrity." Decubitus. 1992;5(5):32-46.
16. Nix DP, Garvin C. Development and Pilot Study: Incontinent skin cleanser protectant lotion. Poster presented at: WOCN 32nd Annual Wound, Ostomy, Continence Conference in conjunction with CAET 19th Annual Conference, June 4-8, 2000, Toronto, Ontario, Canada.
17. Kula J, Nix P, Warshaw E. A multicentered product evaluation of a cleanser protectant lotion containing 2% dimethicone in the treatment of perineal skin breakdown in low-risk incontinent patients from long -term acute care and skilled long term care. Poster presented at: 15th Annual Clinical Symposium on Advances in Skin and Wound Care, October 5-8, 2000, Nashville, Tenn.






Post new comment